CAS 110078-46-1 appears in our catalog under these names: PLERIXAFOR, Plerixafor, >95% (HPLC), Plerixafor (AMD3100), Plerixafor/ 100%, Plerixafor, >98.0%(GC). Offered by: Chemat Brand, TRC, Mikromol, GLPBio, TargetMol. Available pack sizes: on request, 100mg, 25mg, 50mg, 250mg, 10mM (in 1ml ethanol), 5mg, 10mg.
Plerixafor is an azamacrocycle consisting of two cyclam rings connected by a 1,4-phenylenebis(methylene) linker. It is a CXCR4 chemokine receptor antagonist and a hematopoietic stem cell mobilizer. It is used in combination with grulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the perpheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma. It has a role as a C-X-C chemokine receptor type 4 antagonist, an antineoplastic agent, an immunological adjuvant and an anti-HIV agent. It is a member of benzenes, a crown amine, an azacycloalkane, a secondary amino compound, a tertiary amino compound and an azamacrocycle. It is functionally related to a 1,4,8,11-tetraazacyclotetradecane.
Source: ChEBI
| Molecular formula | C28H54N8 |
|---|---|
| Molecular weight | 502.8 g/mol |
| IUPAC name | 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane |
| InChIKey | YIQPUIGJQJDJOS-UHFFFAOYSA-N |
| SMILES | C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3 |
Computed by PubChem (NCBI)